English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination

Dogra, T., Pelz, L., Boehme, J. D., Baelkner, M., Kershaw, O., Marichal-Gallardo, P., et al. (2023). Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. Talk presented at 17th Vaccine Congress. Glasgow (Scotland). 2023-09-24 - 2023-09-27.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Dogra, Tanya1, Author           
Pelz, Lars1, Author           
Boehme, Julia D.2, 3, Author
Baelkner, Maike2, 3, Author
Kershaw, Olivia 4, Author
Marichal-Gallardo, Pavel1, Author           
Gruber, Achim D.4, Author
Genzel, Yvonne1, Author           
Bruder, Dunja2, 3, Author
Kupke, Sascha Young1, Author           
Reichl, Udo1, 2, Author           
Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140              
2Otto-von-Guericke-Universität Magdeburg, External Organizations, ou_1738156              
3Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany, ou_persistent22              
4Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany, ou_persistent22              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2023
 Publication Status: Not specified
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: -
 Degree: -

Event

show
hide
Title: 17<sup>th</sup> Vaccine Congress
Place of Event: Glasgow (Scotland)
Start-/End Date: 2023-09-24 - 2023-09-27

Legal Case

show

Project information

show

Source

show